Neostigmine

Neostigmine

SCHEMBL41903

CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Neostigmine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 14/20 1.00
BCHE P06276 7/20 1.00
LMNA P02545 4/20 0.79
MEN1 O00255 1/20 0.77
KMT2A Q03164 1/20 0.77
NPSR1 Q6W5P4 1/20 0.77
GLA P06280 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.42
GAA P10253 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Neostigmine SCHEMBL7105728 0.93 ACHE (0.87) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL41902 0.92 ACHE (0.85) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL11663910 0.91 ACHE (0.84) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL7576189 0.89 ACHE (0.94) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL8026154 0.89 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL34419 0.89 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL29603805 0.89 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL9987576 0.88 ACHE (0.86) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL2028206 0.88 ACHE (0.89) ACHEBCHELMNAMEN1KMT2A
SCHEMBL29388689 0.88 ACHE (0.78) ACHEBCHELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2322 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076872-A1 POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME SIO2 MEDICAL PRODUCTS LLC (US) 2026-03-19 US claimed
EP-4453129-B1 ELECTRONIC DEVICES SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-04 EP claimed
US-12522624-B2 Electroluminescent material and device thereof Beijing Summer Sprout Technology Co., Ltd. (CN) 2026-01-13 US claimed
US-20250375373-A1 READY-TO-USE INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING NEOSTIGMINE AND GLYCOPYRROLATE AZURITY PHARMACEUTICALS, INC. (US) 2025-12-11 US claimed
US-20250288545-A1 NEOSTIGMINE COMBINATIONS AND COMPOSITIONS DAS-MG, INC. 2025-09-18 US claimed
US-12383491-B2 Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate AZURITY PHARMACEUTICALS, INC. (US) 2025-08-12 US claimed
US-20250242092-A1 SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS SIO2 MEDICAL PRODUCTS INC (US) 2025-07-31 US claimed
CN-119912569-A Anti-SIRP-beta 1 antibodies and methods of use thereof 艾利妥 2025-05-02 CN claimed
WO-2025061694-A1 BIOCOMPATIBLE AND INJECTABLE PHOTOVOLTAIC RETINAL PROSTHESIS AARHUS UNIVERSITET (DK) 2025-03-27 WO claimed
US-12257371-B2 SiOx barrier for pharmaceutical package and coating process SIO2 MEDICAL PRODUCTS, LLC (US) 2025-03-25 US claimed
CN-2329059-Y Quick look-up instrument for incompatibility of drugs in a prescription of 159 kind of injections GU CHUNWEI (CN) 1999-07-14 CN claimed
WO-1999018938-A1 DELAYED TOTAL RELEASE GASTROINTESTINAL DRUG DELIVERY SYSTEM PERIO PRODUCTS LTD. (IL) 1999-04-22 WO claimed
US-5624962-A FOR OPHTHALMIC, DERMATOLOGICAL AND BADY CAVITICAL USE WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1997-04-29 US claimed
EP-0694310-A1 REVERSIBLE, THERMALLY GELLING WATER-BASE MEDICINAL COMPOSITION Wakamoto Pharmaceutical Co., Ltd. (JP) 1996-01-31 EP claimed
CN-1097593-A Aqueous drug composition having property of reversible thermosetting gelation WAKAMOTO PHARMA CO LTD (JP) 1995-01-25 CN claimed
EP-0166724-B1 COMPOSITION FOR TREATING PEDICULOSIS SOFT SHEEN PRODUCTS, INC. (US) 1990-11-22 EP claimed
EP-0166724-A1 COMPOSITION FOR TREATING PEDICULOSIS. SOFT SHEEN PRODUCTS INC (US) 1986-01-08 EP claimed
WO-1985002755-A1 METHOD AND COMPOSITION FOR TREATING PEDICULOSIS SOFT SHEEN PRODUCTS, INC. (US) 1985-07-04 WO claimed
US-4439427-A Method and composition for treating pediculosis SOFT SHEEN PRODUCTS, INC. (US) 1984-03-27 US claimed
US-4098899-A NEOSTIGMINE BROMIDE OR NEOSTIGMINE METHYL SULFATE SCHWARTZ GEORGE R 1978-07-04 US claimed